Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma.
about
Delayed-onset peripheral blood cytopenia after rituximab: frequency and risk factor assessment in a consecutive series of 77 treatments.Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphomaPhase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomas.Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma.Immunoglobulin G Fc receptor FcgammaRIIIa 158 V/F polymorphism correlates with rituximab-induced neutropenia after autologous transplantation in patients with non-Hodgkin's lymphoma.Late-onset neutropenia following rituximab therapy: incidence, clinical features and possible mechanisms.Non-chemotherapy drug-induced agranulocytosis.Stem cell transplantation for chronic lymphocytic leukemia: should not more patients get a transplant?B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis.Stem cell transplantation in follicular lymphoma: progress at last?Delayed-onset grade 4 neutropenia associated with rituximab therapy in a patient with lymphoma: case report and literature review.Evolving role of rituximab in the treatment of patients with non-Hodgkin's lymphoma.Rituximab for the treatment of diffuse large B-cell lymphomas.Rituximab therapy in malignant lymphoma.Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation.The late adverse events of rituximab therapy--rare but there!Development of autoimmunity in lymphoma.Disseminated cryptococcosis in a non-Hodgkin's lymphoma patient with late-onset neutropenia following rituximab-CHOP chemotherapy: a case report and literature review.Late-onset neutropenia following rituximab treatment for rheumatologic conditions.Incidence of late onset neutropenia associated with rituximab use in B cell lymphoma patients undergoing autologous stem cell transplantation.Randomised comparison of two B-cell purging protocols for patients with B-cell non-Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34 cell enrichment device.Impact of rituximab on stem cell mobilization following ACVBP regimen in poor-risk patients with diffuse large B-cell lymphoma: results from a large cohort of patients.A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma.Risk factors for late-onset neutropenia after rituximab treatment of B-cell lymphoma.Drug-Induced Hematological Cytopenia in Kidney Transplantation and the Challenges It Poses for Kidney Transplant Physicians
P2860
Q33371939-EB240380-DD46-40BA-BD46-36FD54B298C1Q33377327-75093854-C7D2-452B-96D0-E681D5312BEFQ33385670-3697C660-17BD-464A-90D5-977D8DBC81C1Q33389752-5020C283-A01D-4899-9BFD-5EB81F744487Q33574197-83504C50-E50D-4860-A4B1-672EF157983FQ33627797-9D10AA98-A660-492F-90AB-CC0E704FABB8Q34072947-ADC7BBC2-DBDF-46E5-88B4-44FDCB02EB9BQ34579237-406E2E41-2378-46E6-92C4-850BD0F005F3Q35819325-2567B306-5B31-40F6-BCE9-BBB50C282634Q35847948-4C02DDEB-68A0-4CE3-9425-C241AE1B6701Q35920882-4D068FD5-77D3-4CE9-AA61-09AEB2E06B61Q36277949-63828B64-BF38-4706-9033-E90EF5418A6EQ36429463-51C93296-8C9F-4660-95C0-A63E71C391A7Q36573823-2F18911D-EAA0-470A-A1B0-A3819615F1B2Q36832102-39551E36-B939-4D33-985D-250E19E02918Q36927025-52A5C191-8DDE-48B0-A53F-BE1F23EA118AQ37462485-04304504-B469-43A7-ADE7-9FB87B9D4C84Q37754707-4190FB53-5BA4-4806-BC61-89A29E8F06A0Q37862618-CD1C977E-51F6-4E33-8240-5DE5FEF08460Q38193735-2EB8D2BF-D1B6-4653-BBF2-910EC5DFE51DQ40272339-2302F5A9-1EEB-44D8-98AD-ABFB059CB2C6Q43881207-D2793EA1-32D6-481D-94EA-04480DF46307Q44233582-8429CF45-AC6D-42E2-9A09-4B8D76FA4B5CQ46365024-BF567C0F-9AEC-443E-978B-F6F25DB2DB6BQ51119875-060089A6-3D3E-48A7-9931-21E63A4B2A34Q58805821-1C712C11-B0EB-49E3-A78D-3018F9C69B1C
P2860
Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Rituximab-related late-onset n ...... essive non-Hodgkin's lymphoma.
@en
Rituximab-related late-onset n ...... essive non-Hodgkin's lymphoma.
@nl
type
label
Rituximab-related late-onset n ...... essive non-Hodgkin's lymphoma.
@en
Rituximab-related late-onset n ...... essive non-Hodgkin's lymphoma.
@nl
prefLabel
Rituximab-related late-onset n ...... essive non-Hodgkin's lymphoma.
@en
Rituximab-related late-onset n ...... essive non-Hodgkin's lymphoma.
@nl
P2093
P2860
P356
P1476
Rituximab-related late-onset n ...... essive non-Hodgkin's lymphoma.
@en
P2093
Alhusein Q
Coiffier B
Espinouse D
Thieblemont C
P2860
P2888
P304
P356
10.1038/SJ.BMT.1704467
P407
P577
2004-05-01T00:00:00Z